TY - JOUR
T1 - Cross sensitization between phencyclidine and methamphetamine
T2 - I. Repeated administration of methamphetamine at a low dose
AU - Nabeshima, T.
AU - Fukaya, H.
AU - Kamei, H.
AU - Ishikawa, K.
AU - Furukawa, H.
AU - Kameyama, T.
PY - 1989
Y1 - 1989
N2 - We investigated whether the effects of phencyclidine (PCP) were modified by repeated pretreatment with methamphetamine (MAP) at a low (3 mg/kg/day for 12 days) dose in rats. The incidence of turning, head-weaving and backpedalling induced by PCP was increased by pretreatment with MAP. In the rats pretreated with MAP, 1) behavioral responses induced by further MAP (a dopamine releaser)-treatment were enhanced, but not those induced by apomorphine (a direct dopamine agonist), 5-methoxy-N,N-dimethyltryptamine (a direct serotonin agonist) and p-chloroamphetamine (a serotonin releaser); 2) dopamine and serotonin contents did not change but the ratio of 3,4-dihydroxyphenylacetic acid to dopamine was increased in the striatum, nucleus accumbens and frontal cortex. These results suggest that repeated administration of MAP (3 mg/kg) increases a presynaptic dopaminergic neuronal activity, but not a serotonergic one, and that there may be cross sensitization to PCP in the dopaminergic neuronal functions following repeated administration of MAP at low dose.
AB - We investigated whether the effects of phencyclidine (PCP) were modified by repeated pretreatment with methamphetamine (MAP) at a low (3 mg/kg/day for 12 days) dose in rats. The incidence of turning, head-weaving and backpedalling induced by PCP was increased by pretreatment with MAP. In the rats pretreated with MAP, 1) behavioral responses induced by further MAP (a dopamine releaser)-treatment were enhanced, but not those induced by apomorphine (a direct dopamine agonist), 5-methoxy-N,N-dimethyltryptamine (a direct serotonin agonist) and p-chloroamphetamine (a serotonin releaser); 2) dopamine and serotonin contents did not change but the ratio of 3,4-dihydroxyphenylacetic acid to dopamine was increased in the striatum, nucleus accumbens and frontal cortex. These results suggest that repeated administration of MAP (3 mg/kg) increases a presynaptic dopaminergic neuronal activity, but not a serotonergic one, and that there may be cross sensitization to PCP in the dopaminergic neuronal functions following repeated administration of MAP at low dose.
UR - http://www.scopus.com/inward/record.url?scp=0024596080&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024596080&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0024596080
SN - 0193-0818
VL - 10
SP - 62
EP - 76
JO - Research Communications in Substances of Abuse
JF - Research Communications in Substances of Abuse
IS - 1
ER -